A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.

Philip J. Mease, I. Jon Russell, Lesley M. Arnold, +4

PubMed

Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies.

Tim West, Yan Hu, Philip B. Verghese, +7

PubMed

Tau PathologyImmunologyPathologyNeurochemical BiomarkersImmunotherapy +16

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça, +70

The Lancet Neurology

Clinical TrialsProgressive Supranuclear PalsyPlacebo-controlled TrialPharmacotherapyPain Management +5

Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study

Hana Florian, Deli Wang, Steven E. Arnold, +9

Brain

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

Hana Florian, Andreas Meier, Serge Gauthier, +6

Journal of Alzheimer s Disease

Safety, tolerability and pharmacokinetics of the histamine H₃ receptor antagonist, <scp>ABT</scp>‐288, in healthy young adults and elderly volunteers

Ahmed A. Othman, George M. Haig, Hana Florian, +3

British Journal of Clinical Pharmacology

Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates

Edward F. Greenberg, Martin J. Voorbach, Alexandra Smith, +26

Heliyon

The H₃antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers

Ahmed A. Othman, George M. Haig, Hana Florian, +3

British Journal of Clinical Pharmacology

O1‐05‐02: EFFICACY AND SAFETY OF THE ALPHA7 AGONIST ABT‐126 AS A MONOTHERAPY TREATMENT IN MILD‐TO‐MODERATE ALZHEIMER'S DEMENTIA: RESULTS OF A PHASE 2B TRIAL

Ahmed A. Othman, Andreas Meier, Craig William Ritchie, +3

Alzheimer s & Dementia

NeuropsychologyPharmacotherapySocial SciencesAlzheimer's DiseaseNeurology +17

[O2–17–01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO‐CONTROLLED STUDY OF ABBV‐8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY ALZHEIMER's DISEASE

Kumar Budur, Tim West, Joel B. Braunstein, +17

Alzheimer s & Dementia

Clinical NeurologyNeurochemical BiomarkersPharmacotherapyAlzheimer's DiseaseClinical Trials +14